SCHEMBL19153230

SCHEMBL19153230

Cc1n[nH]c2c1CS(=O)(=O)CC2

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.33
▸ MAPT P10636 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ HCAR2 Q8TDS4 2/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17232740 0.85 ALDH1A1 (0.30) CYP2C19MAPTHPGD
SCHEMBL17232795 0.82 DYRK1A (0.30) —
SCHEMBL19153671 0.79 PARP1 (0.31) —
SCHEMBL19153920 0.79 PDPK1 (0.31) —
SCHEMBL17229783 0.70 CYP2C19 (0.31) CYP2C19
SCHEMBL12361762 0.67 HCAR2 (0.48) CYP2C19MAPTHPGDHCAR2KMT2A
SCHEMBL12094375 0.67 — —
SCHEMBL18798847 0.67 HSD17B10 (0.36) MAPTHPGD
SCHEMBL13684192 0.67 TSHR (0.37) MAPTHPGDKMT2A
SCHEMBL20674140 0.66 TSHR (0.50) CYP2C19MAPTHPGDHCAR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312585-A1 SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-10-05 — — US disclosed
EP-3495357-B1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE UNIV COLUMBIA (US) 2021-05-05 — — EP disclosed
US-10421720-B2 Octahydrocyclopentapyrroles, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-09-24 — — US disclosed
EP-2968303-B1 OCTAHYDROCYCLOPENTAPYRROLES, THEIR PREPARATION AND USE UNIV COLUMBIA (US) 2018-07-04 — — EP disclosed
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2017-07-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME CD44, MSN, AS3MT CYP2C19 3490/4885MAPT 1162/4885HPGD 4543/4885
US-20230312585-A1 SUBSTITUTED 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE HRH4, HRH3, HRH2 CYP2C19 427/4885MAPT 4510/4885HPGD 3035/4885
US-10421720-B2 Octahydrocyclopentapyrroles, their preparation and use CLN6, ALDH1A2, C1S CYP2C19 3224/4885MAPT 3191/4885HPGD 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback